Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon

被引:38
作者
Herszenyi, Laszlo [1 ]
Sipos, Ferenc [1 ]
Galamb, Orsolya [2 ]
Solymosi, Norbert [1 ]
Hritz, Istvan [1 ]
Miheller, Pal [1 ]
Berczi, Lajos [3 ]
Molnar, Bela [1 ,2 ]
Tulassay, Zsolt [1 ,2 ]
机构
[1] Semmelweis Univ, Dept Med 2, H-1088 Budapest, Hungary
[2] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary
[3] Semmelweis Univ, Dept Pathol & Canc Res 1, H-1088 Budapest, Hungary
关键词
adenoma; colorectal cancer; dysplasia; matrix metalloproteinase-9; polymerase chain reaction;
D O I
10.1007/s12253-008-9004-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been proposed that matrix metalloproteinases (MMPs) play a role in tumor invasion. We determined protein expression of matrix metalloproteinase-9 (MMP-9) in colorectal cancer (CRC), corresponding normal mucosa and colorectal adenomas. For confirmation of immunohistochemical results MMP-9 TaqMan RT-PCR analysis was performed. Expression of MMP-9 was determined on paraffin embedded biopsy sections by immunohistochemistry in 31 CRC patients (from cancer tissue and corresponding normal mucosa) and in 30 patients with adenoma (nine adenomas with high grade of dysplasia). MMP-9 immunostaining was determined semi-quantitatively. For Taqman RT-PCR analyses normal mucosa (n=5), adenoma without (n=6) and with high grade dysplasia (n=7) and CRC (n=10) were investigated. Statistical analysis with ANOVA, LSD test and correlation analysis were performed. P value of <0.05 was considered significant. The MMP-9 expression in CRC was significantly higher compared to adenomas or the normal mucosa (P=0.001). Significantly higher expression of MMP-9 has been observed in adenomas with high grade dysplasia compared to other adenomas or normal colon (P<0.001). Diffuse strong MMP-9 expression was present in tumor as well as in stromal cells. In adenoma samples, dysplastic epithelial cells showed moderate intensive cytoplasmic MMP-9 expression, with a clear-cut differentiation between dysplastic and non-dysplastic areas. Staining intensity correlated with the grade of CRC. We demonstrate a significantly higher expression of MMP-9 in adenoma with high grade dysplasia-CRC sequence as compared to normal tissue. The over-expression of MMP-9 strongly suggests its association with colorectal carcinogenesis.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 66 条
[1]   Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging [J].
Baker, EA ;
Bergin, FG ;
Leaper, DJ .
BRITISH JOURNAL OF SURGERY, 2000, 87 (09) :1215-1221
[2]   Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes [J].
Berger, AC ;
Sigurdson, ER ;
LeVoyer, T ;
Hanlon, A ;
Mayer, RJ ;
Macdonald, JS ;
Catalano, PJ ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8706-8712
[3]   DIRECT EVIDENCE LINKING EXPRESSION OF MATRIX METALLOPROTEINASE-9 (92-KDA GELATINASE/COLLAGENASE) TO THE METASTATIC PHENOTYPE IN TRANSFORMED RAT EMBRYO CELLS [J].
BERNHARD, EJ ;
GRUBER, SB ;
MUSCHEL, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4293-4297
[4]  
Burg-Roderfeld M, 2007, INT J ONCOL, V30, P985
[5]   A phase I pharmacokinetic and pharmacodynamic study of S-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors [J].
Chiappori, Alberto A. ;
Eckhardt, S. Gail ;
Bukowski, Ronald ;
Sullivan, Daniel M. ;
Ikeda, Minoru ;
Yano, Yoshitaka ;
Yamada-Sawada, Takuko ;
Kambayashi, Yoshikaze ;
Tanaka, Kazushige ;
Javle, Milind M. ;
Mekhail, Tarek ;
O'Bryant, Cindy L. ;
Creaven, Patrick J. .
CLINICAL CANCER RESEARCH, 2007, 13 (07) :2091-2099
[6]   Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase [J].
Collins, HM ;
Morris, TM ;
Watson, SA .
BRITISH JOURNAL OF CANCER, 2001, 84 (12) :1664-1670
[7]   Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392
[8]   Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers [J].
Curran, S ;
Dundas, SR ;
Buxton, J ;
Leeman, MF ;
Ramsay, R ;
Murray, GI .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8229-8234
[9]   Plasminogen activation and cancer [J].
Dano, K ;
Behrendt, N ;
Hoyer-Hansen, G ;
Johnsen, M ;
Lund, LR ;
Ploug, M ;
Romer, J .
THROMBOSIS AND HAEMOSTASIS, 2005, 93 (04) :676-681
[10]   The classification of cancer of the rectum [J].
Dukes, CE .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1932, 35 (03) :323-332